Vanguard Group Inc. Purchases 128,400 Shares of Heartflow, Inc. $HTFL

Vanguard Group Inc. raised its stake in shares of Heartflow, Inc. (NASDAQ:HTFL) by 8.8% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 1,580,313 shares of the company’s stock after purchasing an additional 128,400 shares during the quarter. Vanguard Group Inc.’s holdings in Heartflow were worth $46,066,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. Legal & General Group Plc acquired a new position in shares of Heartflow during the 3rd quarter worth about $59,000. Y Intercept Hong Kong Ltd acquired a new position in shares of Heartflow during the 3rd quarter worth about $234,000. Legato Capital Management LLC acquired a new position in shares of Heartflow during the 3rd quarter worth about $243,000. Sandia Investment Management LP acquired a new position in shares of Heartflow during the 3rd quarter worth about $252,000. Finally, Hudson Bay Capital Management LP acquired a new position in shares of Heartflow in the 3rd quarter valued at approximately $288,000.

Analyst Upgrades and Downgrades

HTFL has been the subject of several research analyst reports. JPMorgan Chase & Co. decreased their price objective on Heartflow from $40.00 to $35.00 and set an “overweight” rating for the company in a research report on Thursday, March 19th. Canaccord Genuity Group decreased their price objective on Heartflow from $43.00 to $37.00 and set a “buy” rating for the company in a research report on Friday. William Blair initiated coverage on Heartflow in a research report on Monday, May 4th. They issued an “outperform” rating for the company. Finally, Wells Fargo & Company boosted their price objective on Heartflow from $35.00 to $37.00 and gave the company an “overweight” rating in a research report on Friday. Six research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Heartflow has a consensus rating of “Moderate Buy” and an average price target of $37.00.

Insiders Place Their Bets

In related news, insider Campbell Rogers sold 64,533 shares of the stock in a transaction on Wednesday, April 1st. The stock was sold at an average price of $24.64, for a total value of $1,590,093.12. Following the sale, the insider owned 81,002 shares in the company, valued at approximately $1,995,889.28. This represents a 44.34% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO John C.M. Farquhar sold 22,562 shares of the stock in a transaction on Monday, May 11th. The shares were sold at an average price of $29.12, for a total value of $657,005.44. Following the completion of the sale, the chief executive officer owned 519,397 shares in the company, valued at approximately $15,124,840.64. This trade represents a 4.16% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 2,205,874 shares of company stock worth $64,166,729 in the last quarter. Insiders own 7.70% of the company’s stock.

Heartflow Stock Down 12.2%

Shares of Heartflow stock opened at $28.32 on Friday. Heartflow, Inc. has a 12-month low of $20.13 and a 12-month high of $41.22. The stock has a market cap of $2.44 billion and a P/E ratio of -9.11. The business’s 50 day moving average is $27.28 and its 200-day moving average is $28.87.

Heartflow (NASDAQ:HTFL) last announced its quarterly earnings data on Thursday, May 14th. The company reported ($0.16) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.24) by $0.08. The company had revenue of $52.59 million for the quarter. The company’s revenue was up 41.3% on a year-over-year basis. On average, sell-side analysts expect that Heartflow, Inc. will post -0.78 EPS for the current year.

Heartflow Profile

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.